CDK4/6 inhibitors in advanced breast cancer, what is beyond? by Amrallah A. Mohammed, Hanaa Rashied, Fifi Mostafa Elsayed

Get full text

Target therapy in metastatic pheochromocytoma: current perspectives and controversies by Amrallah A. Mohammed, Ayman M. El-Shentenawy, Mohamed A. Sherisher, Hani M. El-Khatib

Get full text

The pattern of infection and antibiotics use in terminal cancer patients by Amrallah A. Mohammed, Abdullah S. Al-Zahrani, Mohamed A. Sherisher, Ahmad A. Alnagar, Ayman EL-Shentenawy, Amr T. El-Kashif

Get full text

Urinary bladder cancer: biomarkers and target therapy, new era for more attention by Amrallah A. Mohammed, Hani EL-Tanni, Hani M. EL-Khatib, Ahmad A. Mirza, Abdulrahim A. Mirza, Turki H. Alturaifi

Get full text

End-of-life palliative chemotherapy: Where do we stand? by Amrallah A. Mohammed, Abdullah S. Al-Zahrani, Hafez M. Ghanem, Mian U. Farooq, Amr M. El Saify, Hani M. EL-Khatib

Get full text

Impact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer by Amrallah A. Mohammed, Hani EL-Tanni, Hafez M. Ghanem, Mian U. Farooq, Amr M. El Saify, Abdullah S. Al-Zahrani, Ayman EL-Shentenawy, Hani M. EL-Khatib

Get full text